BioCentury | Dec 1, 2020
Emerging Company Profile

Spotlight: solving CRISPR’s delivery challenges with RNPs

...from UC Berkeley and Jacob Corn from ETH Zurich...
BioCentury | Oct 24, 2020
Finance

Oct. 23 Quick Takes: RA Capital’s $461M new fund; plus venture rounds for Sirnaomics, 3D Medicines, Zhaoke, Orbus, Araris

...Swiss antibody-drug conjugate company to CHF15.2 million. A spinout from the Paul Scherrer Institute and ETH Zurich...
BioCentury | Jul 29, 2020
Emerging Company Profile

Bright Peak synthesizing proteins like they’re small molecules with $35M from Versant

...out from the pack. Built by Versant Ventures’ Basel-based Ridgeline outpost with technology licensed from ETH Zurich...
...of variants of that protein,” Mayweg said. The company’s platform, developed in the laboratory of ETH Zurich...
...Therapeutics Inc. San Diego, Calif. Technology: Modified cytokines generated via chemical synthesis Origin of technology: ETH Zurich...
BioCentury | May 27, 2020
Emerging Company Profile

Versant’s Monte Rosa debuts with $32.5M, library of molecular glues for protein degradation

...2018 by Versant, Raj Chopra and Ian Collins University collaborators: The Institute of Cancer Research, ETH Zurich...
BioCentury | May 21, 2020
Emerging Company Profile

Repertoire bets on both sides of the TCR-antigen coin

...is proportional to the strength of the interaction. The MCR technology was originally developed by ETH Zurich...
...Platforms to study TCR-antigen pairings and engineer T cell therapies Origin of technology: Flagship Pioneering, ETH Zurich...
BioCentury | Mar 10, 2020
Finance

Versant builds in Basel, but also takes to Boston, with new investments and spinouts

...in Switzerland, at least for now. Based on technology developed by Jeffrey Bode’s team at ETH Zurich...
BioCentury | Aug 22, 2019
Distillery Techniques

CRISPR-based system for multiplexed gene regulation

...TECHNIQUES CATEGORY: Drug platforms TECHNOLOGY: Gene therapy ETH Zurich researchers reported a single-plasmid CRISPR system that could...
...published online Aug. 12, 2019 doi:10.1038/s41592-019-0508-6 CONTACT: Randall J. Platt, ETH Zurich, Basel, Switzerland email: rplatt@ethz.ch Hongjiang Li ETH Zurich CRISPR...
BioCentury | Aug 21, 2019
Financial News

Aug. 20 Financial Quick Takes: WuXi companies report increased profits; plus Graybug, Araris and Sarepta

...Redalpine, Schroder Adveq and VI Partners. The company spun out from Paul Scherrer Institute and ETH Zurich...
BioCentury | Aug 15, 2019
Preclinical News

Aug. 15 Preclinical Quick Takes: Implicating the tumor microbiome in cancer; plus computational pain classification, multiplexed CRISPR and LUCA

...translation (see "Testing Reflex vs. Reality in Pain" ). Single plasmid for multiplexed CRISPR editing ETH Zurich...
...urogenital diseases (see "Newly Launched LUCA Planning to Tackle Infections in Women" ). Hongjiang Li, Staff Writer ETH Zurich LUCA...
BioCentury | Aug 8, 2019
Translation in Brief

A cool menthol switch for gene expression

...is convenient to use and the system uses humanized components. In the Nature Medicine paper, ETH Zurich...
...corresponding to application or withdrawal of menthol (see Distillery ). Martin Fussenegger, who is an ETH Zurich...
...T cells; TRPM8 - Transient receptor potential cation channel subfamily M member 8 Mary Romeo, Assistant Editor ETH Zurich Senti...
Items per page:
1 - 10 of 56
BioCentury | Dec 1, 2020
Emerging Company Profile

Spotlight: solving CRISPR’s delivery challenges with RNPs

...from UC Berkeley and Jacob Corn from ETH Zurich...
BioCentury | Oct 24, 2020
Finance

Oct. 23 Quick Takes: RA Capital’s $461M new fund; plus venture rounds for Sirnaomics, 3D Medicines, Zhaoke, Orbus, Araris

...Swiss antibody-drug conjugate company to CHF15.2 million. A spinout from the Paul Scherrer Institute and ETH Zurich...
BioCentury | Jul 29, 2020
Emerging Company Profile

Bright Peak synthesizing proteins like they’re small molecules with $35M from Versant

...out from the pack. Built by Versant Ventures’ Basel-based Ridgeline outpost with technology licensed from ETH Zurich...
...of variants of that protein,” Mayweg said. The company’s platform, developed in the laboratory of ETH Zurich...
...Therapeutics Inc. San Diego, Calif. Technology: Modified cytokines generated via chemical synthesis Origin of technology: ETH Zurich...
BioCentury | May 27, 2020
Emerging Company Profile

Versant’s Monte Rosa debuts with $32.5M, library of molecular glues for protein degradation

...2018 by Versant, Raj Chopra and Ian Collins University collaborators: The Institute of Cancer Research, ETH Zurich...
BioCentury | May 21, 2020
Emerging Company Profile

Repertoire bets on both sides of the TCR-antigen coin

...is proportional to the strength of the interaction. The MCR technology was originally developed by ETH Zurich...
...Platforms to study TCR-antigen pairings and engineer T cell therapies Origin of technology: Flagship Pioneering, ETH Zurich...
BioCentury | Mar 10, 2020
Finance

Versant builds in Basel, but also takes to Boston, with new investments and spinouts

...in Switzerland, at least for now. Based on technology developed by Jeffrey Bode’s team at ETH Zurich...
BioCentury | Aug 22, 2019
Distillery Techniques

CRISPR-based system for multiplexed gene regulation

...TECHNIQUES CATEGORY: Drug platforms TECHNOLOGY: Gene therapy ETH Zurich researchers reported a single-plasmid CRISPR system that could...
...published online Aug. 12, 2019 doi:10.1038/s41592-019-0508-6 CONTACT: Randall J. Platt, ETH Zurich, Basel, Switzerland email: rplatt@ethz.ch Hongjiang Li ETH Zurich CRISPR...
BioCentury | Aug 21, 2019
Financial News

Aug. 20 Financial Quick Takes: WuXi companies report increased profits; plus Graybug, Araris and Sarepta

...Redalpine, Schroder Adveq and VI Partners. The company spun out from Paul Scherrer Institute and ETH Zurich...
BioCentury | Aug 15, 2019
Preclinical News

Aug. 15 Preclinical Quick Takes: Implicating the tumor microbiome in cancer; plus computational pain classification, multiplexed CRISPR and LUCA

...translation (see "Testing Reflex vs. Reality in Pain" ). Single plasmid for multiplexed CRISPR editing ETH Zurich...
...urogenital diseases (see "Newly Launched LUCA Planning to Tackle Infections in Women" ). Hongjiang Li, Staff Writer ETH Zurich LUCA...
BioCentury | Aug 8, 2019
Translation in Brief

A cool menthol switch for gene expression

...is convenient to use and the system uses humanized components. In the Nature Medicine paper, ETH Zurich...
...corresponding to application or withdrawal of menthol (see Distillery ). Martin Fussenegger, who is an ETH Zurich...
...T cells; TRPM8 - Transient receptor potential cation channel subfamily M member 8 Mary Romeo, Assistant Editor ETH Zurich Senti...
Items per page:
1 - 10 of 56